Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

213,391-213,420 of 319,975

filter-aware
11
The slide outlines the financial impact of Section 45X and state-level incentives on the Giga America project.Freyr | Results Presentation Deck | 19 slides · FREYR
Conference presentation Investor relations Beat · Action1 hit
12
The slide uses a structured list format to present three core pillars of the decision.Freyr | Results Presentation Deck | 19 slides · FREYR
Conference presentation Investor relations Beat · Action1 hit
13
The chart is a waterfall-bridge showing cash flow components.Freyr | Results Presentation Deck | 19 slides · FREYR
Conference presentation Investor relations Beat · Action1 hit
14
Uses a hub-and-spoke diagram to illustrate capital formation strategy.Freyr | Results Presentation Deck | 19 slides · FREYR
Conference presentation Investor relations Beat · Action1 hit
15
The slide outlines a multi-pronged capital strategy involving equity, debt, and government grants/incentives.Freyr | Results Presentation Deck | 19 slides · FREYR
Conference presentation Investor relations Beat · Action1 hit
16
Uses a comparison frame to illustrate why EV and ESS markets are decoupling.Freyr | Results Presentation Deck | 19 slides · FREYR
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
17
The slide uses stacked bar charts to visualize regional supply/demand balances for LFP batteries.Freyr | Results Presentation Deck | 19 slides · FREYR
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
18
Freyr | Results Presentation Deck | 19 slidesFreyr | Results Presentation Deck | 19 slides · FREYR
Conference presentation Investor relations Beat · Action1 hit
19
The slide uses a high-quality photograph of a worker in a FREYR facility as a background.Freyr | Results Presentation Deck | 19 slides · FREYR
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Fusion Pharmaceuticals | Investor Presentation Deck | 33 slidesFusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
02
Fusion Pharmaceuticals | Investor Presentation Deck | 33 slidesFusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
03
The slide uses a combination of bulleted benefits and a visual process diagram to explain Targeted Alpha Therapy.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
04
The slide uses a process-oriented layout to highlight vertical integration.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Solution1 hit
05
The slide uses a Gantt-style visualization to represent clinical trial progress.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Solution1 hit
06
The slide uses a two-column layout to contrast supply partnerships with internal manufacturing infrastructure.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Solution1 hit
07
Includes a logo grid of past/affiliated companies at the bottom.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Team1 hit
08
Fusion Pharmaceuticals | Investor Presentation Deck | 33 slidesFusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
09
Includes a clinical imaging case study (A-D) showing patient response over time.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
10
Includes specific clinical study citation (Zacherl et al. 2021).Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
11
Includes competitive benchmarking context in the footer notes regarding Endocyte and POINT clinical trial data sizes.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Product1 hit
12
The slide illustrates the transition from a 177Lu-based molecule (IPN-1087) to a 225Ac-based molecule (FPI-2059) to improve efficacy.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Product1 hit
13
The slide outlines a standard 3+3 dose escalation clinical trial design for a radiopharmaceutical.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Product1 hit
14
Fusion Pharmaceuticals | Investor Presentation Deck | 33 slidesFusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
15
The slide uses a waterfall plot comparison to contrast clinical outcomes of two different therapeutic modalities.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
16
The slide uses a PET scan image to demonstrate selective tumor uptake versus normal tissue, and a table to quantify IGF-1R expression across different cancer types.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
17
The slide uses a process flow diagram to map out different study arms (Single Ascending Dose, CASS, Multiple Dose Escalation, and Cold/Hot Dosing).Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
18
FPI-1434 clinical data presentation.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
19
The slide outlines two main pillars of the collaboration: targeted alpha therapies and combination therapies.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
20
The slide uses a Y-shaped antibody diagram to illustrate bispecific binding.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
21
The slide highlights a 'vaccine effect' in 13/15 animals and mentions IP protection for these combinations.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit